APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI in Pathology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI in Pathology Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchAI in Pathology Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Pathology Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI in Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Pathology Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Pathology Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global AI in Pathology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI in Pathology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI in Pathology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI in Pathology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI in Pathology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI in Pathology market include Koninklijke Philips N.V., F.Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc. and Optrascan, Inc. (Optra Ventures, LLC), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI in Pathology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI in Pathology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI in Pathology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI in Pathology market.

AI in Pathology Segment by Company

Koninklijke Philips N.V.

F.Hoffmann-La Roche Ltd.

Hologic, Inc.

Visiopharm A/S

Paige AI, Inc.

PathAI, Inc.

Aiforia Technologies Plc

Indica Labs, Inc.

Optrascan, Inc. (Optra Ventures, LLC)

MindPeak GmbH

AI in Pathology Segment by Type

Convolutional neural networks (CNNs)

Generative adversarial networks (GANs)

Recurrent neural networks (RNNs)

Others

AI in Pathology Segment by Application

Pharmaceutical & Biotechnology Companies

Hospitals & Reference Laboratories

Academic & Research Institutes

AI in Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI in Pathology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI in Pathology key companies, revenue, market share, and recent developments.

3. To split the AI in Pathology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI in Pathology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI in Pathology significant trends, drivers, influence factors in global and regions.

6. To analyze AI in Pathology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI in Pathology industry.

Chapter 3: Detailed analysis of AI in Pathology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI in Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI in Pathology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI in Pathology Industry Trends Table 2. AI in Pathology Industry Drivers Table 3. AI in Pathology Industry Opportunities and Challenges Table 4. AI in Pathology Industry Restraints Table 5. Global AI in Pathology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI in Pathology Revenue Share by Company (2021-2026) Table 7. Global AI in Pathology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI in Pathology Key Company Manufacturing Base & Headquarters Table 9. Global AI in Pathology Company, Product Type & Application Table 10. Global AI in Pathology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI in Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Convolutional neural networks (CNNs) Table 15. Significant Companies of Generative adversarial networks (GANs) Table 16. Significant Companies of Recurrent neural networks (RNNs) Table 17. Significant Companies of Others Table 18. Global AI in Pathology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI in Pathology Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI in Pathology Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI in Pathology Sales Value Share by Type (2021-2026) Table 22. Global AI in Pathology Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical & Biotechnology Companies Table 24. Significant Companies of Hospitals & Reference Laboratories Table 25. Significant Companies of Academic & Research Institutes Table 26. Global AI in Pathology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI in Pathology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI in Pathology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI in Pathology Sales Value Share by Application (2021-2026) Table 30. Global AI in Pathology Sales Value Share by Application (2027-2032) Table 31. Global AI in Pathology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI in Pathology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI in Pathology Sales Value Share by Region (2021-2026) Table 34. Global AI in Pathology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI in Pathology Sales Value Share by Region (2027-2032) Table 36. Global AI in Pathology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI in Pathology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI in Pathology Sales Value Market Share by Country (2021-2026) Table 39. Global AI in Pathology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI in Pathology Sales Value Market Share by Country (2027-2032) Table 41. Koninklijke Philips N.V. Company Information Table 42. Koninklijke Philips N.V. Business Overview Table 43. Koninklijke Philips N.V. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Koninklijke Philips N.V. AI in Pathology Product Portfolio Table 45. Koninklijke Philips N.V. Recent Development Table 46. F.Hoffmann-La Roche Ltd. Company Information Table 47. F.Hoffmann-La Roche Ltd. Business Overview Table 48. F.Hoffmann-La Roche Ltd. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. F.Hoffmann-La Roche Ltd. AI in Pathology Product Portfolio Table 50. F.Hoffmann-La Roche Ltd. Recent Development Table 51. Hologic, Inc. Company Information Table 52. Hologic, Inc. Business Overview Table 53. Hologic, Inc. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Hologic, Inc. AI in Pathology Product Portfolio Table 55. Hologic, Inc. Recent Development Table 56. Visiopharm A/S Company Information Table 57. Visiopharm A/S Business Overview Table 58. Visiopharm A/S AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Visiopharm A/S AI in Pathology Product Portfolio Table 60. Visiopharm A/S Recent Development Table 61. Paige AI, Inc. Company Information Table 62. Paige AI, Inc. Business Overview Table 63. Paige AI, Inc. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Paige AI, Inc. AI in Pathology Product Portfolio Table 65. Paige AI, Inc. Recent Development Table 66. PathAI, Inc. Company Information Table 67. PathAI, Inc. Business Overview Table 68. PathAI, Inc. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PathAI, Inc. AI in Pathology Product Portfolio Table 70. PathAI, Inc. Recent Development Table 71. Aiforia Technologies Plc Company Information Table 72. Aiforia Technologies Plc Business Overview Table 73. Aiforia Technologies Plc AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Aiforia Technologies Plc AI in Pathology Product Portfolio Table 75. Aiforia Technologies Plc Recent Development Table 76. Indica Labs, Inc. Company Information Table 77. Indica Labs, Inc. Business Overview Table 78. Indica Labs, Inc. AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Indica Labs, Inc. AI in Pathology Product Portfolio Table 80. Indica Labs, Inc. Recent Development Table 81. Optrascan, Inc. (Optra Ventures, LLC) Company Information Table 82. Optrascan, Inc. (Optra Ventures, LLC) Business Overview Table 83. Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product Portfolio Table 85. Optrascan, Inc. (Optra Ventures, LLC) Recent Development Table 86. MindPeak GmbH Company Information Table 87. MindPeak GmbH Business Overview Table 88. MindPeak GmbH AI in Pathology Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MindPeak GmbH AI in Pathology Product Portfolio Table 90. MindPeak GmbH Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. AI in Pathology Product Image Figure 2. Global AI in Pathology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI in Pathology Market Size (2021-2032) & (US$ Million) Figure 4. Global AI in Pathology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Convolutional neural networks (CNNs) Image Figure 8. Generative adversarial networks (GANs) Image Figure 9. Recurrent neural networks (RNNs) Image Figure 10. Others Image Figure 11. Global AI in Pathology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI in Pathology Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI in Pathology Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical & Biotechnology Companies Image Figure 15. Hospitals & Reference Laboratories Image Figure 16. Academic & Research Institutes Image Figure 17. Global AI in Pathology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI in Pathology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI in Pathology Sales Value Share by Application (2021-2032) Figure 20. Global AI in Pathology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI in Pathology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI in Pathology Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI in Pathology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI in Pathology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI in Pathology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI in Pathology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI in Pathology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI in Pathology Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI in Pathology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI in Pathology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI in Pathology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI in Pathology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI in Pathology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI in Pathology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Convolutional neural networks (CNNs)
  • Generative adversarial networks (GANs)
  • Recurrent neural networks (RNNs)
  • Others
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Reference Laboratories
  • Academic & Research Institutes
Companies covered
  • Koninklijke Philips N.V.
  • F.Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI in Pathology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI in Pathology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI in Pathology Market Dynamics
  1. 2.1 AI in Pathology Industry Trends
  2. 2.2 AI in Pathology Industry Drivers
  3. 2.3 AI in Pathology Industry Opportunities and Challenges
  4. 2.4 AI in Pathology Industry Restraints
3 AI in Pathology Market by Company
  1. 3.1 Global AI in Pathology Company Revenue Ranking in 2025
  2. 3.2 Global AI in Pathology Revenue by Company (2021-2026)
  3. 3.3 Global AI in Pathology Company Ranking (2024-2026)
  4. 3.4 Global AI in Pathology Company Manufacturing Base and Headquarters
  5. 3.5 Global AI in Pathology Company Product Type and Application
  6. 3.6 Global AI in Pathology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI in Pathology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI in Pathology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI in Pathology Market by Type
  1. 4.1 AI in Pathology Type Introduction
  2. 4.1.1 Convolutional neural networks (CNNs)
  3. 4.1.2 Generative adversarial networks (GANs)
  4. 4.1.3 Recurrent neural networks (RNNs)
  5. 4.1.4 Others
  6. 4.2 Global AI in Pathology Sales Value by Type
  7. 4.2.1 Global AI in Pathology Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI in Pathology Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI in Pathology Sales Value Share by Type (2021-2032)
5 AI in Pathology Market by Application
  1. 5.1 AI in Pathology Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospitals & Reference Laboratories
  4. 5.1.3 Academic & Research Institutes
  5. 5.2 Global AI in Pathology Sales Value by Application
  6. 5.2.1 Global AI in Pathology Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI in Pathology Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI in Pathology Sales Value Share by Application (2021-2032)
6 AI in Pathology Regional Value Analysis
  1. 6.1 Global AI in Pathology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI in Pathology Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI in Pathology Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI in Pathology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI in Pathology Sales Value (2021-2032)
  7. 6.3.2 North America AI in Pathology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI in Pathology Sales Value (2021-2032)
  10. 6.4.2 Europe AI in Pathology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI in Pathology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI in Pathology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI in Pathology Sales Value (2021-2032)
  16. 6.6.2 South America AI in Pathology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI in Pathology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI in Pathology Sales Value Share by Country, 2025 VS 2032
7 AI in Pathology Country-level Value Analysis
  1. 7.1 Global AI in Pathology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI in Pathology Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI in Pathology Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI in Pathology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI in Pathology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI in Pathology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI in Pathology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI in Pathology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI in Pathology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI in Pathology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI in Pathology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI in Pathology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI in Pathology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI in Pathology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI in Pathology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI in Pathology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI in Pathology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI in Pathology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI in Pathology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI in Pathology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI in Pathology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI in Pathology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI in Pathology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI in Pathology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI in Pathology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI in Pathology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI in Pathology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI in Pathology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI in Pathology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI in Pathology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI in Pathology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI in Pathology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI in Pathology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI in Pathology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI in Pathology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI in Pathology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI in Pathology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI in Pathology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI in Pathology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI in Pathology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI in Pathology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI in Pathology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI in Pathology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI in Pathology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI in Pathology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI in Pathology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI in Pathology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI in Pathology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI in Pathology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI in Pathology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI in Pathology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI in Pathology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI in Pathology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI in Pathology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI in Pathology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI in Pathology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI in Pathology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI in Pathology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI in Pathology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI in Pathology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI in Pathology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI in Pathology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI in Pathology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI in Pathology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI in Pathology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI in Pathology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI in Pathology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI in Pathology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI in Pathology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI in Pathology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI in Pathology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI in Pathology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI in Pathology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI in Pathology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI in Pathology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI in Pathology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI in Pathology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI in Pathology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI in Pathology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI in Pathology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI in Pathology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI in Pathology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI in Pathology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI in Pathology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI in Pathology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI in Pathology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI in Pathology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI in Pathology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Koninklijke Philips N.V.
  2. 8.1.1 Koninklijke Philips N.V. Company Information
  3. 8.1.2 Koninklijke Philips N.V. Business Overview
  4. 8.1.3 Koninklijke Philips N.V. AI in Pathology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Koninklijke Philips N.V. AI in Pathology Product Portfolio
  6. 8.1.5 Koninklijke Philips N.V. Recent Developments
  7. 8.2 F.Hoffmann-La Roche Ltd.
  8. 8.2.1 F.Hoffmann-La Roche Ltd. Company Information
  9. 8.2.2 F.Hoffmann-La Roche Ltd. Business Overview
  10. 8.2.3 F.Hoffmann-La Roche Ltd. AI in Pathology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 F.Hoffmann-La Roche Ltd. AI in Pathology Product Portfolio
  12. 8.2.5 F.Hoffmann-La Roche Ltd. Recent Developments
  13. 8.3 Hologic, Inc.
  14. 8.3.1 Hologic, Inc. Company Information
  15. 8.3.2 Hologic, Inc. Business Overview
  16. 8.3.3 Hologic, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hologic, Inc. AI in Pathology Product Portfolio
  18. 8.3.5 Hologic, Inc. Recent Developments
  19. 8.4 Visiopharm A/S
  20. 8.4.1 Visiopharm A/S Company Information
  21. 8.4.2 Visiopharm A/S Business Overview
  22. 8.4.3 Visiopharm A/S AI in Pathology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Visiopharm A/S AI in Pathology Product Portfolio
  24. 8.4.5 Visiopharm A/S Recent Developments
  25. 8.5 Paige AI, Inc.
  26. 8.5.1 Paige AI, Inc. Company Information
  27. 8.5.2 Paige AI, Inc. Business Overview
  28. 8.5.3 Paige AI, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Paige AI, Inc. AI in Pathology Product Portfolio
  30. 8.5.5 Paige AI, Inc. Recent Developments
  31. 8.6 PathAI, Inc.
  32. 8.6.1 PathAI, Inc. Company Information
  33. 8.6.2 PathAI, Inc. Business Overview
  34. 8.6.3 PathAI, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PathAI, Inc. AI in Pathology Product Portfolio
  36. 8.6.5 PathAI, Inc. Recent Developments
  37. 8.7 Aiforia Technologies Plc
  38. 8.7.1 Aiforia Technologies Plc Company Information
  39. 8.7.2 Aiforia Technologies Plc Business Overview
  40. 8.7.3 Aiforia Technologies Plc AI in Pathology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aiforia Technologies Plc AI in Pathology Product Portfolio
  42. 8.7.5 Aiforia Technologies Plc Recent Developments
  43. 8.8 Indica Labs, Inc.
  44. 8.8.1 Indica Labs, Inc. Company Information
  45. 8.8.2 Indica Labs, Inc. Business Overview
  46. 8.8.3 Indica Labs, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Indica Labs, Inc. AI in Pathology Product Portfolio
  48. 8.8.5 Indica Labs, Inc. Recent Developments
  49. 8.9 Optrascan, Inc. (Optra Ventures, LLC)
  50. 8.9.1 Optrascan, Inc. (Optra Ventures, LLC) Company Information
  51. 8.9.2 Optrascan, Inc. (Optra Ventures, LLC) Business Overview
  52. 8.9.3 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product Portfolio
  54. 8.9.5 Optrascan, Inc. (Optra Ventures, LLC) Recent Developments
  55. 8.10 MindPeak GmbH
  56. 8.10.1 MindPeak GmbH Company Information
  57. 8.10.2 MindPeak GmbH Business Overview
  58. 8.10.3 MindPeak GmbH AI in Pathology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MindPeak GmbH AI in Pathology Product Portfolio
  60. 8.10.5 MindPeak GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst